Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07058818 · ClinicalTrials.gov registry record · NA

Tailored Resistance Training After Adverse Pregnancy Outcomes

A NA study of Postpartum and Adverse Pregnancy Outcomes, sponsored by University of Michigan.

Recruiting
Registry status
NA
Development phase
10
Enrollment target
1
Study location

NCT07058818 is a NA study of Postpartum and Adverse Pregnancy Outcomes that is actively recruiting participants, run by University of Michigan. The registered enrollment target is 10 participants, below the 250-participant average among 16 other Postpartum trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07058818, a NA study of Postpartum and Adverse Pregnancy Outcomes, is actively recruiting participants, sponsored by University of Michigan.

RECRUITING
Registry status
NA
Development phase
10 participants
Enrollment target
1
Study location

Study Summary

Approximately 7-10 postpartum people with recent adverse pregnancy outcomes (APOs: preeclampsia, gestational diabetes, hypertensive disorders of pregnancy, fetal growth restriction or low birth weight baby, or preterm birth) will be invited to complete 4 weeks of a resistance training intervention, including associated incentives, communication, and marketing materials.

Interventions

  • BEHAVIORAL Resistance training

Study Locations (1)

Michigan

  • School of Kinesiology - Ann Arbor

Trial Details

FieldValue
Enrollment Target 10 participants
Start Date 2026-01-08
Est. Completion 2026-05
Phase NA

Sponsor

University of Michigan

1,327 total trials

What the Registry Record Tells You About NCT07058818

The ClinicalTrials.gov registry entry for NCT07058818 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 250-participant average among 16 other Postpartum trials with a reported enrollment target (96% lower). The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Postpartum appearing as the primary indexed condition, and to 1 intervention - of which Resistance training is the first listed.

NCT07058818 reports 1 study location spanning 1 distinct geographic area - top geographies include Michigan.

Frequently Asked Questions

What is clinical trial NCT07058818 about?

NCT07058818 is a clinical study titled "Tailored Resistance Training After Adverse Pregnancy Outcomes". Approximately 7-10 postpartum people with recent adverse pregnancy outcomes (APOs: preeclampsia, gestational diabetes, hypertensive disorders of pregnancy, fetal growth restriction or low birth weight baby, or preterm birth) will be invited to complete 4 weeks of a resistance training intervention, ...

What is the current status of trial NCT07058818?

This trial is currently recruiting. It is a NA study. The enrollment target is 10 participants. The study started on 2026-01-08. Estimated completion is 2026-05.

What conditions does trial NCT07058818 study?

This clinical trial studies the following conditions: Postpartum, Adverse Pregnancy Outcomes.

What interventions are being tested in trial NCT07058818?

The interventions under investigation include: Resistance training (BEHAVIORAL).

Who is sponsoring clinical trial NCT07058818?

This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07058818 being conducted?

This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Postpartum

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.